Synageva and to-BBB partner to evaluate compounds for transporting therapeutics across the blood-brain barrier to treat rare diseases, including Lysosomal Storage Diseases

to-BBB technologies B.V.

the Netherlands / Private Biopharma

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Synageva BioPharma Corp.

U.S. / Mid-Cap Biopharma ($1-$50 billion)

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced